Drug intelligence / Profile preview

clobetasone butyrate + hydrocortisone acetate

Development stage: Unknown
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration: Topical

Overview

Clobetasone butyrate + hydrocortisone acetate is a topical combination of two corticosteroids used to reduce inflammation, itching, and redness associated with various skin conditions such as eczema and dermatitis. Both components are synthetic glucocorticoid corticosteroids that act by suppressing the inflammatory response in the skin. Clobetasone butyrate is considered a moderately potent topical steroid, while hydrocortisone acetate is classified as mild to moderate in potency. The combination aims to provide enhanced anti-inflammatory effects for short-term management of steroid-responsive dermatoses.

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on clobetasone butyrate + hydrocortisone acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on clobetasone butyrate + hydrocortisone acetate.

Explore the full profile